RLMD
NASDAQ
$5
Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to treat central nervous system (CNS) diseases and other disorders in the United States. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $12.67 (+153.40%)
Market Cap
$651M
Free Cash Flow Yield
-6.57%
Beta (5Y)
0.89
Price Chart
Valuation
Market Cap$651M
P/S9001.90
P/B2.97
Profitability
EBITDA-$59M
EPS-$1.05
Financial Health
Free Cash Flow Yield-6.57%
Growth & Risk
EPS 5Y CAGR-0.59%
FCF 5Y CAGR+1.12%
Beta (5Y)0.89
Sharpe Ratio2.28